EU green light for Roche’s Tecentriq
admin 25th September 2017 Uncategorised 0Anti-PD-L1 cancer immunotherapy approved to treat specific lung and bladder cancers
More: EU green light for Roche’s Tecentriq
Source: News
Anti-PD-L1 cancer immunotherapy approved to treat specific lung and bladder cancers
More: EU green light for Roche’s Tecentriq
Source: News
© 1994 - 2023 B.M. Pharmaceuticals